MPM BioVentures 2014, L.P.'s Form 4 filing
Werewolf Therapeutics, Inc. (HOWL) · filed Dec 4, 2025
- Accession no.
- 0001231919-25-000575
- Filed
- Dec 4, 2025, 6:19 PM ET
- Trade date
- Dec 2-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $183.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| MPM BioVentures 2014, L.P.CIK 0001609492 | Other: Former 10% Owner |
| MPM BioVentures 2014 (B), L.P.CIK 0001609493 | Other: Former 10% Owner |
| MPM Asset Management Investors BV2014 LLCCIK 0001609495 | Other: Former 10% Owner |
| MPM BioVentures 2014 LLCCIK 0001765021 | Other: Former 10% Owner |
| MPM BioVentures 2014 GP LLCCIK 0001765091 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | SSaleDisposed | −59,277 | $0.89F3 | −$52,756.53 | 4,924,566 | Indirect | Duplicate filing |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −57,225 | $0.87F7 | −$49,785.75 | 4,867,341 | Indirect | Duplicate filing |
| Dec 4, 2025 | Common Stock | SSaleDisposed | −83,230 | $0.97F10 | −$80,733.1 | 4,784,111 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.852 to $0.9246 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.9256 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.92 to $1.0208 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
This filing is 1 of 2 identical filings due to limitations on number of Reporting Persons. See Form 4 filed by Ansbert Gadicke.